Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?

Ítems similars

• SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer
  per: Tabbò, Fabrizio, et al.
  Publicat: (2019)
• Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations
  per: Bironzo, Paolo, et al.
  Publicat: (2021)
• Epidermal growth factor receptor tyrosine kinase inhibitors
  per: Ranson, M
  Publicat: (2004)
• Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
  per: Zhai, Haoran, et al.
  Publicat: (2015)
• Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease
  per: Ohashi, Kadoaki, et al.
  Publicat: (2013)